D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 72 Citations 19,211 271 World Ranking 13903 National Ranking 7311

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

His main research concerns Internal medicine, Immunology, Lupus nephritis, Kidney disease and Lupus erythematosus. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology. His Immunology study integrates concerns from other disciplines, such as Biomarker, Glomerulonephritis and Allele.

His Lupus nephritis research is multidisciplinary, incorporating perspectives in Discontinuation, Treatment outcome, Systemic lupus erythematosus, Cytokine TWEAK and Nephritis. His Kidney disease study combines topics in areas such as Adverse effect and Intensive care medicine. His work carried out in the field of Proteinuria brings together such families of science as Nephropathy, Kidney metabolism, Clinical trial and Renal function.

His most cited work include:

  • The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility (1075 citations)
  • Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis (781 citations)
  • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study† (763 citations)

What are the main themes of his work throughout his whole career to date?

Brad H. Rovin focuses on Internal medicine, Lupus nephritis, Immunology, Kidney and Kidney disease. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology. Brad H. Rovin focuses mostly in the field of Lupus nephritis, narrowing it down to topics relating to Systemic lupus erythematosus and, in certain cases, Immunosuppression.

Brad H. Rovin has included themes like Glomerulonephritis and Disease in his Immunology study. As part of one scientific family, Brad H. Rovin deals mainly with the area of Kidney, narrowing it down to issues related to the Acute kidney injury, and often Nephrectomy. His research investigates the connection with Proteinuria and areas like Renal function which intersect with concerns in Placebo.

He most often published in these fields:

  • Internal medicine (45.29%)
  • Lupus nephritis (35.26%)
  • Immunology (33.43%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (45.29%)
  • Lupus nephritis (35.26%)
  • Kidney (24.32%)

In recent papers he was focusing on the following fields of study:

Brad H. Rovin spends much of his time researching Internal medicine, Lupus nephritis, Kidney, Proteinuria and Immunology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Placebo. The study incorporates disciplines such as Glomerulonephritis, Inflammation, Adverse effect, Systemic lupus erythematosus and Nephritis in addition to Lupus nephritis.

His Kidney research incorporates elements of Kidney disease, Nephropathy, Biopsy, Pathology and Acute kidney injury. His Kidney disease research integrates issues from Immunosuppression and Intensive care medicine. His Proteinuria study incorporates themes from Nephrotic syndrome and Cohort.

Between 2018 and 2021, his most popular works were:

  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy (94 citations)
  • Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. (85 citations)
  • A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. (72 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Internal medicine, Lupus nephritis, Kidney disease, Proteinuria and Kidney are his primary areas of study. His biological study spans a wide range of topics, including Gastroenterology and Placebo. His Lupus nephritis research includes elements of Renal pathology, Adverse effect, Systemic lupus erythematosus, Biopsy and Cohort.

His Kidney disease study combines topics from a wide range of disciplines, such as Native kidney, Immunosuppression, Surgery and Intensive care medicine. Brad H. Rovin interconnects Acute kidney injury and Apoptosis in the investigation of issues within Kidney. The Nephrology study combines topics in areas such as Glomerulonephritis and Transplantation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility

Enrique Gonzalez;Hemant Kulkarni;Hector Bolivar;Andrea Mangano.
Science (2005)

1370 Citations

Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu.
Kidney International (2012)

1224 Citations

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler.
Journal of The American Society of Nephrology (2009)

1059 Citations

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†

Brad H. Rovin;Richard Furie;Kevin Latinis;R. John Looney.
Arthritis & Rheumatism (2012)

1011 Citations

A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.

Brad H. Rovin;Ling Lu;Ramesh Saxena.
Biochemical and Biophysical Research Communications (1999)

625 Citations

Gene Copy-Number Variation and Associated Polymorphisms of Complement Component C4 in Human Systemic Lupus Erythematosus (SLE): Low Copy Number Is a Risk Factor for and High Copy Number Is a Protective Factor against SLE Susceptibility in European Americans

Yan Yang;Erwin K. Chung;Yee Ling Wu;Stephanie L. Savelli.
American Journal of Human Genetics (2007)

587 Citations

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.

John C. Byrd;Thomas S. Lin;James T. Dalton;Di Wu.
Blood (2007)

442 Citations

Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression.

Xi-Lin Chen;Geraldine Dodd;Suzanne Thomas;Xiaolan Zhang.
American Journal of Physiology-heart and Circulatory Physiology (2006)

442 Citations

Update on Lupus Nephritis

Salem Almaani;Alexa Meara;Brad H. Rovin.
Clinical Journal of The American Society of Nephrology (2017)

381 Citations

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

Enrique Gonzalez;Brad H. Rovin;Luisa Sen;Glen Cooke.
Proceedings of the National Academy of Sciences of the United States of America (2002)

344 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Brad H. Rovin

David A. Isenberg

David A. Isenberg

University College London

Publications: 58

Michelle Petri

Michelle Petri

Johns Hopkins University School of Medicine

Publications: 55

Chaim Putterman

Chaim Putterman

Albert Einstein College of Medicine

Publications: 48

John C. Byrd

John C. Byrd

University of Cincinnati

Publications: 44

Evan E. Eichler

Evan E. Eichler

University of Washington

Publications: 43

Tak Mao Chan

Tak Mao Chan

University of Hong Kong

Publications: 43

David Jayne

David Jayne

University of Cambridge

Publications: 41

Fernando C. Fervenza

Fernando C. Fervenza

Mayo Clinic

Publications: 39

John B. Harley

John B. Harley

Cincinnati Children's Hospital Medical Center

Publications: 39

Gerald B. Appel

Gerald B. Appel

Columbia University

Publications: 38

Sunil K. Ahuja

Sunil K. Ahuja

The University of Texas Health Science Center at San Antonio

Publications: 38

Alberto Ortiz

Alberto Ortiz

Autonomous University of Madrid

Publications: 37

Michael R. Grever

Michael R. Grever

The Ohio State University

Publications: 36

Chandra Mohan

Chandra Mohan

University of Houston

Publications: 36

Hans-Joachim Anders

Hans-Joachim Anders

Ludwig-Maximilians-Universität München

Publications: 35

Dimitrios T. Boumpas

Dimitrios T. Boumpas

National and Kapodistrian University of Athens

Publications: 34

Trending Scientists

Mark S. Manasse

Mark S. Manasse

Microsoft (United States)

Anbo Wang

Anbo Wang

Virginia Tech

Jami J. Shah

Jami J. Shah

The Ohio State University

James D. White

James D. White

Oregon State University

Hans M. Christen

Hans M. Christen

Oak Ridge National Laboratory

Mingyao Li

Mingyao Li

University of Pennsylvania

Amanda E. Bates

Amanda E. Bates

Memorial University of Newfoundland

Esther van der Knaap

Esther van der Knaap

University of Georgia

Beat Frey

Beat Frey

Swiss Federal Institute for Forest, Snow and Landscape Research

Peter E. Braun

Peter E. Braun

McGill University

R. D. Moore

R. D. Moore

University of British Columbia

Ole Petter Ottersen

Ole Petter Ottersen

University of Oslo

Emmanuel Mellet

Emmanuel Mellet

University of Bordeaux

Jennifer A. Epstein

Jennifer A. Epstein

Cornell University

Heinz Jungbluth

Heinz Jungbluth

King's College London

Charles Duyckaerts

Charles Duyckaerts

Université Paris Cité

Something went wrong. Please try again later.